Using the hemoglobin switch for the treatment of sickle cell diseaseCOOLS, Jan.Haematologica (Roma). 2012, Vol 97, Num 2, issn 0390-6078, p. 156Article

Primetime for chemotherapy in acute myeloid leukemiaCOOLS, Jan.Haematologica (Roma). 2012, Vol 97, Num 12, issn 0390-6078, p. 1775Article

Culturele archiefwerking : balanceren tussen bevoegdheden en het erfgoedbeleid = Cultural archival working: between competences and heritage policyCOOLS, Jan.Bibliotheek- en archiefgids - Vlaamse vereniging voor bibliotheek-, archief-, en documentatiewezen. 2006, Vol 82, Num 5, pp 3-8, issn 0772-7003, 6 p.Article

Novel Approaches to Therapy of Hypereosinophilic SyndromesSIMON, Hans-Uwe; COOLS, Jan.Immunology and allergy clinics of North America. 2007, Vol 27, Num 3, issn 0889-8561, viii, 519-527 [10 p.]Article

Genetic insights in the pathogenesis of T-cell acute lymphoblastic leukemiaDE KEERSMAECKER, Kim; MARYNEN, Peter; COOLS, Jan et al.Haematologica (Roma). 2005, Vol 90, Num 8, pp 1116-1127, issn 0390-6078, 12 p.Article

MOHITO, a novel mouse cytokine-dependent T-cell line, enables studies of oncogenic signaling in the T-cell contextKLEPPE, Maria; MENTENS, Nicole; TOUSSEYN, Thomas et al.Haematologica (Roma). 2011, Vol 96, Num 5, pp 779-783, issn 0390-6078, 5 p.Article

The kinase inhibitor TKI258 is active against the novel CUX1-FGFR1 fusion detected in a patient with T-lymphoblastic leukemia/lymphoma and t(7;8)(q22;p11)WASAG, Bartosz; LIERMAN, Els; MEEUS, Peter et al.Haematologica (Roma). 2011, Vol 96, Num 6, pp 922-926, issn 0390-6078, 5 p.Article

Mutation of the receptor tyrosine phosphatase PTPRC (CD45) in T-cell acute lymphoblastic leukemiaPORCU, Michael; KLEPPE, Maria; MACINTYRE, Elizabeth et al.Blood. 2012, Vol 119, Num 19, pp 4476-4479, issn 0006-4971, 4 p.Article

The genetic basis of early T-cell precursor acute lymphoblastic leukaemiaJINGHUI ZHANG; LI DING; LU, Charles et al.Nature (London). 2012, Vol 481, Num 7380, pp 157-163, issn 0028-0836, 7 p.Article

FIP1L1/PDGFRα synergizes with SCF to induce systemic mastocytosis in a murine model of chronic eosinophilic leukemia/hypereosinophilic syndrome. CommentaryCOOLS, Jan; YAMADA, Yoshiyuki; SANCHEZ-AGUILERA, Abel et al.Blood. 2008, Vol 112, Num 6, issn 0006-4971, 2179, 2500-2507 [9 p.]Article

The recurrent SET-NUP214 fusion as a new HOXA activation mechanism in pediatric T-cell acute lymphoblastic leukemiaVAN VLIERBERGHE, Pieter; VAN GROTEL, Martine; BUIJS-GLADDINES, Jessica et al.Blood. 2008, Vol 111, Num 9, pp 4668-4680, issn 0006-4971, 13 p.Article

Duplication of the MYB oncogene in T cell acute lymphoblastic leukemiaLAHORTIGA, Idoya; DE KEERSMAECKER, Kim; ODERO, Maria D et al.Nature genetics. 2007, Vol 39, Num 5, pp 593-595, issn 1061-4036, 3 p.Article

PTPN2 negatively regulates oncogenic JAK1 in T-cell acute lymphoblastic leukemiaKLEPPE, Maria; SOULIER, Jean; TARTAGLIA, Marco et al.Blood. 2011, Vol 117, Num 26, pp 7090-7098, issn 0006-4971, 9 p.Article

Mutation analysis of the tyrosine phosphatase PTPN2 in Hodgkin's lymphoma and T-cell non-Hodgkin's lymphomaKLEPPE, Maria; TOUSSEYN, Thomas; GEISSINGER, Eva et al.Haematologica (Roma). 2011, Vol 96, Num 11, pp 1723-1727, issn 0390-6078, 5 p.Article

The ability of sorafenib to inhibit oncogenic PDGFRβ and FLT3 mutants and overcome resistance to other small molecule inhibitorsLIERMAN, Els; LAHORTIGA, Idoya; VAN MIEGROET, Helen et al.Haematologica (Roma). 2007, Vol 92, Num 1, pp 27-34, issn 0390-6078, 8 p.Article

Efficacy of the kinase inhibitor SU11248 against gastrointestinal stromal tumor mutants refractory to imatinib mesylatePRENEN, Hans; COOLS, Jan; MENTENS, Nicole et al.Clinical cancer research. 2006, Vol 12, Num 8, pp 2622-2627, issn 1078-0432, 6 p.Article

Sorafenib is a potent inhibitor of FIP1L1-PDGFRα and the imatinib-resistant FIP1L1-PDGFRα T674I mutantLIERMAN, Els; FOLENS, Cedric; STOVER, Elizabeth H et al.Blood. 2006, Vol 108, Num 4, pp 1374-1376, issn 0006-4971, 3 p.Article

The NPM-ALK and the ATIC-ALK fusion genes can be detected in non-neoplastic cellsMAES, Brigitte; VANHENTENRIJK, Vera; WLODARSKA, Iwona et al.The American journal of pathology. 2001, Vol 158, Num 6, pp 2185-2193, issn 0002-9440Article

Activity of imatinib in systemic mastocytosis with chronic basophilic leukemia and a PRKG2-PDGFRB fusionLAHORTIGA, Idoya; AKIN, Cem; LESSIN, Lawrence S et al.Haematologica (Roma). 2008, Vol 93, Num 1, pp 49-56, issn 0390-6078, 8 p.Article

The EOL-1 cell line as an in vitro model for the study of FIP1L1-PDGFRA-positive chronic eosinophilic leukemiaCOOLS, Jan; QUENTMEIER, Hilmar; HUNTLY, Brian J. P et al.Blood. 2004, Vol 103, Num 7, pp 2802-2805, issn 0006-4971, 4 p.Article

The FIP1L1-PDGFRα kinase in hypereosinophilic syndrome and chronic eosinophilic leukemiaCOOLS, Jan; STOVER, Elizabeth H; WLODARSKA, Iwona et al.Current opinion in hematology. 2004, Vol 11, Num 1, pp 51-57, issn 1065-6251, 7 p.Article

A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target ofimatinib in idiopathic hypereosinophilic syndromeCOOLS, Jan; DEANGELO, Daniel J; CROSS, Nicholas C. P et al.The New England journal of medicine. 2003, Vol 348, Num 13, pp 1201-1214, issn 0028-4793, 14 p.Article

JAK2 rearrangements, including the novel SEC31A-JAK2 fusion, are recurrent in classical Hodgkin lymphomaVAN ROOSBROECK, Katrien; COX, Luk; DE WOLF-PEETERS, Chris et al.Blood. 2011, Vol 117, Num 15, pp 4056-4064, issn 0006-4971, 9 p.Article

ALK-positive large B-cell lymphomas with cryptic SEC31A-ALK and NPM1-ALK fusionsVAN ROOSBROECK, Katrien; COOLS, Jan; DIERICKX, Daan et al.Haematologica (Roma). 2010, Vol 95, Num 3, pp 509-513, issn 0390-6078, 5 p.Article

Page / 2